Adenocarcinoma of the Pancreas Not Yet Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03871959Pembrolizumab In Combination With Debio 1143 In Pancreatic and Colorectal Advanced/Metastatic AdenocarcinomaTreatment